Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. CA: A Cancer Journal for Clinicians, 73, 17–48. https://doi.org/10.3322/caac.21763
Cancer Statistics Review, 1975–2012 – Previous Version – SEER Cancer Statistics Review. In: SEER. https://seer.cancer.gov/archive/csr/1975_2012/index.html. Accessed 22 Feb 2023.
Ferreira, A. R., Meglio, A. D., Pistilli, B., et al. (2019). Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: A prospective patient-reported outcomes analysis. Annals of Oncology, 30, 1784–1795. https://doi.org/10.1093/annonc/mdz298
Article CAS PubMed Google Scholar
Dumas, A., Vaz Luis, I., Bovagnet, T., et al. (2020). Impact of breast cancer treatment on employment: Results of a multicenter prospective cohort study (CANTO). Journal of Clinical Oncology, 38, 734–743. https://doi.org/10.1200/JCO.19.01726
Article CAS PubMed Google Scholar
Firkins, J., Hansen, L., Driessnack, M., & Dieckmann, N. (2020). Quality of life in “chronic” cancer survivors: A meta-analysis. Journal of Cancer Survivorship, 14, 504–517. https://doi.org/10.1007/s11764-020-00869-9
Pinto, A. C., & de Azambuja, E. (2011). Improving quality of life after breast cancer: Dealing with symptoms. Maturitas, 70, 343–348. https://doi.org/10.1016/j.maturitas.2011.09.008
Hamer, J., McDonald, R., Zhang, L., et al. (2017). Quality of life (QOL) and symptom burden (SB) in patients with breast cancer. Supportive Care in Cancer, 25, 409–419. https://doi.org/10.1007/s00520-016-3417-6
Jim, H. S. L., Hoogland, A. I., Brownstein, N. C., et al. (2020). Innovations in research and clinical care using patient-generated health data. CA: A Cancer Journal for Clinicians, 70, 182–199. https://doi.org/10.3322/caac.21608
Atkinson, T. M., Li, Y., Coffey, C. W., et al. (2012). Reliability of adverse symptom event reporting by clinicians. Quality of Life Research, 21, 1159–1164. https://doi.org/10.1007/s11136-011-0031-4
Basch, E., Iasonos, A., McDonough, T., et al. (2006). Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: Results of a questionnaire-based study. The lancet Oncology, 7, 903–909. https://doi.org/10.1016/S1470-2045(06)70910-X
Laugsand, E. A., Sprangers, M. A. G., Bjordal, K., et al. (2010). Health care providers underestimate symptom intensities of cancer patients: A multicenter European study. Health and Quality of Life Outcomes, 8, 104. https://doi.org/10.1186/1477-7525-8-104
Article PubMed PubMed Central Google Scholar
EMA. (2018). Regulatory guidance for the use of health-related quality life (HRQL) measures in evaluation medicinal products – Scientific guideline. In: Eur. Med. Agency. https://www.ema.europa.eu/en/regulatory-guidance-use-health-related-quality-life-hrql-measures-evaluation-medicinal-products. Accessed 28 June 2023.
U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. (2006). Guidance for industry: Patient-reported outcome measures: Use in medical product development to support labeling claims: Draft guidance. Health and Quality of Life Outcomes, 4, 79. https://doi.org/10.1186/1477-7525-4-79
NICE health technology evaluations: the manual
Cherny, N. I., Sullivan, R., Dafni, U., et al. (2016). ESMO – Magnitude of clinical benefit scale V.1.0 questions and answers. ESMO Open, 1, e000100. https://doi.org/10.1136/esmoopen-2016-000100
Article CAS PubMed PubMed Central Google Scholar
Wild, D., Grove, A., Martin, M., et al. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value Health, 8, 94–104. https://doi.org/10.1111/j.1524-4733.2005.04054.x
Papadakos, J. K., Charow, R. C., Papadakos, C. J., et al. (2019). Evaluating cancer patient-reported outcome measures: Readability and implications for clinical use. Cancer, 125, 1350–1356. https://doi.org/10.1002/cncr.31928
NIH. (2015). Clear & simple. In: Natl. Inst. Health NIH. https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/clear-communication/clear-simple. Accessed 23 Feb 2023.
Weiss, B. D. (2003). Health literacy a manual for clinicians. http://lib.ncfh.org/pdfs/6617.pdf. Accessed 27 July 2022.
Sørensen, K., Pelikan, J. M., Röthlin, F., et al. (2015). Health literacy in Europe: Comparative results of the European health literacy survey (HLS-EU). European Journal of Public Health, 25, 1053–1058. https://doi.org/10.1093/eurpub/ckv043
Article PubMed PubMed Central Google Scholar
20 % de la population dispose d’un diplôme supérieur à bac + 2 – Centre d’observation de la société. https://www.observationsociete.fr/education/donnees-generales/population-par-diplome/. Accessed 28 July 2023.
Ousseine, Y. M., Bouhnik, A.-D., & Mancini, J. (2022). Health literacy and clinical trial participation in French cancer patients: A national survey. Current Oncology, 29, 3118–3129. https://doi.org/10.3390/curroncol29050253
Article PubMed PubMed Central Google Scholar
Di Meglio, A., Havas, J., Gbenou, A. S., et al. (2022). Dynamics of long-term patient-reported quality of life and health behaviors after adjuvant breast cancer chemotherapy. Journal of Clinical Oncology, 40, 3190–3204. https://doi.org/10.1200/JCO.21.00277
Article CAS PubMed PubMed Central Google Scholar
Vaz-Luis, I., Cottu, P., Mesleard, C., et al. (2019). UNICANCER: French prospective cohort study of treatment-related chronic toxicity in women with localised breast cancer (CANTO). ESMO Open, 4, e000562. https://doi.org/10.1136/esmoopen-2019-000562
Article PubMed PubMed Central Google Scholar
Lapidari, P., Havas, J., Presti, D., et al. (2022). Abstract P3–12–12: ATTITUDE: Understanding and reducing ATTrition in longiTUDinal studiEs of cancer survivors. Cancer Res, 82, P3-12. https://doi.org/10.1158/1538-7445.SABCS21-P3-12-12
Zebrack, B. J., Ganz, P. A., Bernaards, C. A., et al. (2006). Assessing the impact of cancer: Development of a new instrument for long-term survivors. Psycho-Oncology, 15, 407–421. https://doi.org/10.1002/pon.963
Article PubMed PubMed Central Google Scholar
Beck, A. T., Guth, D., Steer, R. A., & Ball, R. (1997). Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behaviour Research and Therapy, 35, 785–791. https://doi.org/10.1016/s0005-7967(97)00025-9
Article CAS PubMed Google Scholar
Beck, A. T., & Steer, R. A. (1984). Internal consistencies of the original and revised Beck Depression Inventory. Journal of Clinical Psychology, 40, 1365–1367. https://doi.org/10.1002/1097-4679(198411)40:6%3c1365::aid-jclp2270400615%3e3.0.co;2-d
Article CAS PubMed Google Scholar
Bull, F. C., Maslin, T. S., & Armstrong, T. (2009). Global physical activity questionnaire (GPAQ): Nine country reliability and validity study. Journal of Physical Activity & Health, 6, 790–804. https://doi.org/10.1123/jpah.6.6.790
Aaronson, N. K., Ahmedzai, S., Bergman, B., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376. https://doi.org/10.1093/jnci/85.5.365
Article CAS PubMed Google Scholar
Sprangers, M. A., Groenvold, M., Arraras, J. I., et al. (1996). The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study. J Clin Oncol Off J Am Soc Clin Oncol, 14, 2756–2768. https://doi.org/10.1200/JCO.1996.14.10.2756
Weis, J., Tomaszewski, K. A., Hammerlid, E., et al. (2017). International psychometric validation of an EORTC quality of life module measuring cancer related fatigue (EORTC QLQ-FA12). Journal of the National Cancer Institute, 109, djw273. https://doi.org/10.1093/jnci/djw273
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scand., 67, 361–370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
Ware, J., Kosinski, M., & Keller, S. D. (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34, 220–233. https://doi.org/10.1097/00005650-199603000-00003
Scheier, M. F., Carver, C. S., & Bridges, M. W. (1994). Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): A reevaluation of the Life Orientation Test. Journal of Personality and Social Psychology, 67, 1063–1078. https://doi.org/10.1037//0022-3514.67.6.1063
Article CAS PubMed Google Scholar
Élaboration d’un document écrit d’information à l’intention des patients et des usagers du système de santé. In: Haute Aut. Santé. https://www.has-sante.fr/jcms/c_430286/fr/elaboration-d-un-document-ecrit-d-information-a-l-intention-des-patients-et-des-usagers-du-systeme-de-sante. Accessed 24 Feb 2023.
Friedman, D. B., & Hoffman-Goetz, L. (2006). A systematic review of readability and comprehension instruments used for print and web-based cancer information. Health Education & Behavior, 33, 352–373. https://doi.org/10.1177/1090198105277329
Conquet, A., & Richaudeau, F. (1973). Cinq méthodes de mesure de la lisibilité. Commun Lang, 17, 5–16. https://doi.org/10.3406/colan.1973.3978
U.S. Department of Health and Human Services, Centers for Medicare & Medicaid Services Using readability formulas: A cautionary note. https://www.montefiore.org/documents/ToolkitPart07.pdf. Accessed 28 July 2023.
The Patient Education Materials Assessment Tool (PEMAT) and User’s Guide. https://www.ahrq.gov/health-literacy/patient-education/pemat.html. Accessed 24 Feb 2023.
Clerehan, R., Guillemin, F., Epstein, J., & Buchbinder, R. (2016). Using the evaluative linguistic framework for questionnaires to assess comprehensibility of self-report health questionnaires. Value Health, 19, 335–342. https://doi.org/10.1016/j.jval.2016.01.008
Comments (0)